News Breaks |
|
|
| December 14, 2012 |
| 19:07 EDT |  | NVS | FDA approves Novartis' Signifor drug for Cushing’s disease
The U.S. Food and Drug Administration today approved Signifor injection for the treatment of Cushing’s disease patients who cannot be helped through surgery. The FDA is requiring three postmarketing studies for Signifor: a clinical trial to assess high blood sugar management; a long-term prospective observational cohort study of patients with Cushing’s disease treated with Signifor; and focused safety monitoring for reports of serious hyperglycemia, acute liver injury, and adrenal insufficiency. Signifor is manufactured by Novartis (NVS). Reference Link |
|
|
News For NVS From The Last 14 Days Check below for free stories on NVS the last two weeks. |
|
|
| May 24, 2013 |
| 08:22 EDT |  | NVS | Leerink's biotech analysts hold an analyst/industry conference call
 Subscribe for More Information |
|
| May 21, 2013 |
| 07:44 EDT | | NVS | Sachs Associates to host a forum
Subscribe for More Information |
|
| 07:24 EDT | | NVS | Global Health Care to host a conference
Subscribe for More Information |
|
| May 20, 2013 |
| 07:29 EDT | | NVS | Deutsche Bank to host a conference
dbAccess Asia Conference 2013 is being held in Singapore on May 20-22. |
|
| May 17, 2013 |
| 16:20 EDT | | NVS | Novartis drug Afinitor extended time without disease progression in women
Subscribe for More Information |
|
| May 16, 2013 |
| 08:11 EDT | | NVS | Novartis says no intention of pursuing Actavis, Bloomberg reports
Subscribe for More Information |
|
| May 15, 2013 |
| 19:37 EDT |  | NVS | Novartis weighing Actavis bid, WSJ reports
Subscribe for More Information |
|
| 18:17 EDT | | NVS | Novartis weighs possible bid for Actavis, DJ reports
Subscribe for More Information |
|
| May 10, 2013 |
| 05:42 EDT | | NVS | Novartis drug Ilaris approved by FDA
Subscribe for More Information |
|
|
|
|
|
